Results
|
2021.
|
High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation. [electronic resource] by
- De Freitas, Tiago
- Marktel, Sarah
- Piemontese, Simona
- Carrabba, Matteo G
- Tresoldi, Cristina
- Messina, Carlo
- Lupo Stanghellini, Maria Teresa
- Assanelli, Andrea
- Corti, Consuelo
- Bernardi, Massimo
- Peccatori, Jacopo
- Vago, Luca
- Ciceri, Fabio
Producer: 20170206
In:
European journal of haematology vol. 96
Availability: No items available.
|
|
2022.
|
|
|
2023.
|
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML. [electronic resource] by
- Takahashi, K
- Jabbour, E
- Wang, X
- Luthra, R
- Bueso-Ramos, C
- Patel, K
- Pierce, S
- Yang, H
- Wei, Y
- Daver, N
- Faderl, S
- Ravandi, F
- Estrov, Z
- Cortes, J
- Kantarjian, H
- Garcia-Manero, G
Producer: 20131210
In:
Leukemia vol. 27
Availability: No items available.
|
|
2024.
|
Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha. [electronic resource] by
- Kurosawa, Saiko
- Yamaguchi, Hiroki
- Yamaguchi, Takuhiro
- Fukunaga, Keiko
- Yui, Shunsuke
- Wakita, Satoshi
- Kanamori, Heiwa
- Usuki, Kensuke
- Uoshima, Nobuhiko
- Yanada, Masamitsu
- Shono, Katsuhiro
- Ueki, Toshimitsu
- Mizuno, Ishikazu
- Yano, Shingo
- Takeuchi, Jin
- Kanda, Junya
- Okamura, Hiroshi
- Inamoto, Yoshihiro
- Inokuchi, Koiti
- Fukuda, Takahiro
Producer: 20180212
In:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation vol. 22
Availability: No items available.
|
|
2025.
|
Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD. [electronic resource] by
- Chien, W
- Sun, Q-Y
- Ding, L-W
- Mayakonda, A
- Takao, S
- Liu, L
- Lim, S L
- Tan, K T
- Garg, M
- De Sousa Maria Varela, A
- Xiao, J
- Jacob, N
- Behrens, K
- Stocking, C
- Lill, M
- Madan, V
- Hattori, N
- Gery, S
- Ogawa, S
- Wakita, S
- Ikezoe, T
- Shih, L-Y
- Alpermann, T
- Haferlach, T
- Yang, H
- Koeffler, H P
Producer: 20180605
In:
Leukemia vol. 31
Availability: No items available.
|
|
2026.
|
|
|
2027.
|
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia. [electronic resource] by
- Sasaki, Koji
- Kantarjian, Hagop M
- Kadia, Tapan
- Patel, Keyur
- Loghavi, Sanam
- Garcia-Manero, Guillermo
- Jabbour, Elias J
- DiNardo, Courtney
- Pemmaraju, Naveen
- Daver, Naval
- Dalle, Iman Abou
- Short, Nicholas
- Yilmaz, Musa
- Bose, Prithviraj
- Naqvi, Kiran
- Pierce, Sherry
- Yalniz, Fevzi
- Cortes, Jorge E
- Ravandi, Farhad
Producer: 20200526
In:
Cancer vol. 125
Availability: No items available.
|
|
2028.
|
Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. [electronic resource] by
- Radomska, Hanna S
- Bassères, Daniela S
- Zheng, Rui
- Zhang, Pu
- Dayaram, Tajhal
- Yamamoto, Yukiya
- Sternberg, David W
- Lokker, Nathalie
- Giese, Neill A
- Bohlander, Stefan K
- Schnittger, Susanne
- Delmotte, Marie-Hélène
- Davis, Roger J
- Small, Donald
- Hiddemann, Wolfgang
- Gilliland, D Gary
- Tenen, Daniel G
Producer: 20060403
In:
The Journal of experimental medicine vol. 203
Availability: No items available.
|
|
2029.
|
Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy. [electronic resource] by
- Koopman, Gerrit
- Mortier, D
- Niphuis, H
- Farese, Ann M
- Kahn, Larry E
- Mann, Dean
- Wagner, Ralf
- MacVittie, Thomas J
- Woulfe, Susan L
- Heeney, Jonathan L
Producer: 20051027
In:
Vaccine vol. 23
Availability: No items available.
|
|
2030.
|
|
|
2031.
|
FLT3 K663Q is a novel AML-associated oncogenic kinase: Determination of biochemical properties and sensitivity to Sunitinib (SU11248). [electronic resource] by
- Schittenhelm, M M
- Yee, K W H
- Tyner, J W
- McGreevey, L
- Haley, A D
- Town, A
- Griffith, D J
- Bainbridge, T
- Braziel, R M
- O'Farrell, A-M
- Cherrington, J M
- Heinrich, M C
Producer: 20061205
In:
Leukemia vol. 20
Availability: No items available.
|
|
2032.
|
|
|
2033.
|
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. [electronic resource] by
- Garzon, Ramiro
- Garofalo, Michela
- Martelli, Maria Paola
- Briesewitz, Roger
- Wang, Lisheng
- Fernandez-Cymering, Cecilia
- Volinia, Stefano
- Liu, Chang-Gong
- Schnittger, Susanne
- Haferlach, Torsten
- Liso, Arcangelo
- Diverio, Daniela
- Mancini, Marco
- Meloni, Giovanna
- Foa, Robin
- Martelli, Massimo F
- Mecucci, Cristina
- Croce, Carlo M
- Falini, Brunangelo
Producer: 20080407
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 105
Availability: No items available.
|
|
2034.
|
|
|
2035.
|
|
|
2036.
|
IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia and associated with NPM1 mutations and FAB-M2 subtype. [electronic resource] by
- Chao, H-Y
- Jia, Z-X
- Chen, T
- Lu, X-Z
- Cen, L
- Xiao, R
- Jiang, N-K
- Ying, J-H
- Zhou, M
- Zhang, R
Producer: 20130212
In:
International journal of laboratory hematology vol. 34
Availability: No items available.
|
|
2037.
|
SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants. [electronic resource] by
- Cao, Z-X
- Liu, J-J
- Zheng, R-L
- Yang, J
- Zhong, L
- Xu, Y
- Wang, L-J
- Zhang, C-H
- Wang, B-L
- Ma, S
- Wang, Z-R
- Xie, H-Z
- Wei, Y-Q
- Yang, S-Y
Producer: 20121119
In:
Leukemia vol. 26
Availability: No items available.
|
|
2038.
|
Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. [electronic resource] by
- Sengsayadeth, S M
- Jagasia, M
- Engelhardt, B G
- Kassim, A
- Strickland, S A
- Goodman, S
- Lucid, C
- Vnencak-Jones, C L
- Greer, J P
- Savani, B N
Producer: 20130910
In:
Bone marrow transplantation vol. 47
Availability: No items available.
|
|
2039.
|
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3-ITD. [electronic resource] by
- Takahashi, Koichi
- Kantarjian, Hagop
- Pemmaraju, Naveen
- Andreeff, Michael
- Borthakur, Gautam
- Faderl, Stefan
- Garcia-Manero, Guillermo
- Pierce, Sherry
- Luthra, Rajyalakshmi
- Cardenas-Turanzas, Marylou
- Estrov, Zeev
- Ravandi, Farhad
- Cortes, Jorge
Producer: 20130708
In:
British journal of haematology vol. 161
Availability: No items available.
|
|
2040.
|
Discovery of novel N-(5-(tert-butyl)isoxazol-3-yl)-N'-phenylurea analogs as potent FLT3 inhibitors and evaluation of their activity against acute myeloid leukemia in vitro and in vivo. [electronic resource] by
- Xu, Ying
- Wang, Ning-Yu
- Song, Xue-Jiao
- Lei, Qian
- Ye, Ting-Hong
- You, Xin-Yu
- Zuo, Wei-Qiong
- Xia, Yong
- Zhang, Li-Dan
- Yu, Luo-Ting
Producer: 20160517
In:
Bioorganic & medicinal chemistry vol. 23
Availability: No items available.
|